BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrew MK, Bowles SK, Pawelec G, Haynes L, Kuchel GA, McNeil SA, McElhaney JE. Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications. Drugs Aging 2019;36:29-37. [PMID: 30411283 DOI: 10.1007/s40266-018-0597-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Brooks BD, Beland A, Aguero G, Taylor N, Towne FD. Moving beyond Titers. Vaccines 2022;10:683. [DOI: 10.3390/vaccines10050683] [Reference Citation Analysis]
2 Chevalier-Cottin EP, Ashbaugh H, Brooke N, Gavazzi G, Santillana M, Burlet N, Tin Tin Htar M. Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases. Infect Dis Ther 2020;9:467-80. [PMID: 32583334 DOI: 10.1007/s40121-020-00312-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Andrew MK, Schmader KE, Rockwood K, Clarke B, McElhaney JE. Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist. Clin Interv Aging 2021;16:731-8. [PMID: 33953551 DOI: 10.2147/CIA.S295522] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wagner A, Weinberger B. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Front Immunol 2020;11:717. [PMID: 32391017 DOI: 10.3389/fimmu.2020.00717] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
5 Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer APS, Daubenberger C, Brentani A. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med 2020:bmjebm-2020-111549. [PMID: 33310766 DOI: 10.1136/bmjebm-2020-111549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
6 Sadarangani M, Abu Raya B, Conway JM, Iyaniwura SA, Falcao RC, Colijn C, Coombs D, Gantt S. Importance of COVID-19 vaccine efficacy in older age groups. Vaccine 2021;39:2020-3. [PMID: 33736921 DOI: 10.1016/j.vaccine.2021.03.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Balasubramani GK, Choi WS, Nowalk MP, Zimmerman RK, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Jackson ML, Jackson LA, Chung JR, Spencer S, Fry AM, Patel M, Flannery B; US Flu VE Network Investigators. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. Vaccine 2020;38:6562-9. [PMID: 32800465 DOI: 10.1016/j.vaccine.2020.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Divino V, Ruthwik Anupindi V, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ, Levin MJ. A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States. Open Forum Infect Dis 2022;9:ofab604. [PMID: 35028334 DOI: 10.1093/ofid/ofab604] [Reference Citation Analysis]
9 Calabrò GE, Boccalini S, Panatto D, Rizzo C, Di Pietro ML, Abreha FM, Ajelli M, Amicizia D, Bechini A, Giacchetta I, Lai PL, Merler S, Primieri C, Trentini F, Violi S, Bonanni P, de Waure C. The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment. Int J Environ Res Public Health 2022;19:4166. [PMID: 35409848 DOI: 10.3390/ijerph19074166] [Reference Citation Analysis]
10 Bartoszko J, Loeb M. The burden of influenza in older adults: meeting the challenge. Aging Clin Exp Res 2021;33:711-7. [PMID: 31347085 DOI: 10.1007/s40520-019-01279-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rosales-Mendoza S, Márquez-Escobar VA, González-Ortega O, Nieto-Gómez R, Arévalo-Villalobos JI. What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? Vaccines (Basel) 2020;8:E183. [PMID: 32295153 DOI: 10.3390/vaccines8020183] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
12 Berkhout C, De Man J, Collins C, Willefert-Bouche A, Zgorska-Maynard Moussa S, Badelon M, Peremans L, Van Royen P. Reanalysis of a Randomized Controlled Trial on Promoting Influenza Vaccination in General Practice Waiting Rooms: A Zelen Design. Vaccines (Basel) 2022;10:826. [PMID: 35632583 DOI: 10.3390/vaccines10050826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Eshraghi Y, Vahdani Y, Karimi P, Abdollahpour-Alitappeh M, Abdoli A, Taghizadeh M, Mahdavi M. Immunomodulatory Effects of α-Tocopherol on the H1N1 Influenza Vaccine: Improving the Potency and Efficacy of the Influenza Vaccine in Aged Mice. Viral Immunol 2022;35:244-53. [PMID: 35467429 DOI: 10.1089/vim.2021.0154] [Reference Citation Analysis]
14 Li APY, Cohen CA, Leung NHL, Fang VJ, Gangappa S, Sambhara S, Levine MZ, Iuliano AD, Perera RAPM, Ip DKM, Peiris JSM, Thompson MG, Cowling BJ, Valkenburg SA. Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. NPJ Vaccines 2021;6:25. [PMID: 33594050 DOI: 10.1038/s41541-021-00289-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Jabr Alwazzeh M, Mohammed Telmesani L, Saud AlEnazi A, Abdulwahab Buohliqah L, Talal Halawani R, Jatoi NA, Subbarayalu AV, Abdulaziz Almuhanna F. Seasonal influenza vaccination coverage and its association with COVID-19 in Saudi Arabia. Inform Med Unlocked 2021;27:100809. [PMID: 34869828 DOI: 10.1016/j.imu.2021.100809] [Reference Citation Analysis]
16 Witkowski JM. Immune system aging and the aging-related diseases in the COVIID-19 era. Immunology Letters 2022. [DOI: 10.1016/j.imlet.2022.01.005] [Reference Citation Analysis]
17 Morris L, Swofford S. Vaccine Safety. Prim Care 2020;47:431-41. [PMID: 32718441 DOI: 10.1016/j.pop.2020.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lapi F, Marconi E, Gualano MR, Vetrano DL, Grattagliano I, Rossi A, Cricelli C. A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications. Drugs Aging 2022. [PMID: 35867212 DOI: 10.1007/s40266-022-00958-7] [Reference Citation Analysis]
19 Noé A, Cargill TN, Nielsen CM, Russell AJC, Barnes E. The Application of Single-Cell RNA Sequencing in Vaccinology. J Immunol Res 2020;2020:8624963. [PMID: 32802896 DOI: 10.1155/2020/8624963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Fan R, Huang X, Nian X, Ou Z, Zhou J, Zhang J, Zeng P, Zhao W, Deng J, Chen W, Chen S, Duan K, Chen Y, Li X, Zhang J, Yang X. Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study. Hum Vaccin Immunother 2021;:1-9. [PMID: 34473607 DOI: 10.1080/21645515.2021.1967041] [Reference Citation Analysis]
21 Mahmood A, Kim H, Kabir U, Kedia S, Ray M. Food Insecurity and Influenza and Pneumonia Vaccines Uptake Among Community-Dwelling Older Adults in the United States. J Community Health 2020;45:943-53. [PMID: 32219711 DOI: 10.1007/s10900-020-00812-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Privor-Dumm L, Vasudevan P, Kobayashi K, Gupta J. Archetype analysis of older adult immunization decision-making and implementation in 34 countries. Vaccine 2020;38:4170-82. [PMID: 32376108 DOI: 10.1016/j.vaccine.2020.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 [DOI: 10.1101/2020.06.29.20142505] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
24 Colrat F, Thommes E, Largeron N, Alvarez FP. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review. Vaccine 2021;39 Suppl 1:A42-50. [PMID: 33518466 DOI: 10.1016/j.vaccine.2020.12.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cassimos DC, Effraimidou E, Medic S, Konstantinidis T, Theodoridou M, Maltezou HC. Vaccination Programs for Adults in Europe, 2019. Vaccines (Basel) 2020;8:E34. [PMID: 31968652 DOI: 10.3390/vaccines8010034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
26 Rong H, Lai X, Ma X, Hou Z, Li S, Jing R, Zhang H, Peng Z, Feng L, Fang H. Seasonal Influenza Vaccination and Recommendation: The Difference between General Practitioners and Public Health Workers in China. Vaccines (Basel) 2020;8:E265. [PMID: 32486350 DOI: 10.3390/vaccines8020265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Gianchecchi E, Torelli A, Montomoli E. The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity. Hum Vaccin Immunother 2019;15:1021-30. [PMID: 30614754 DOI: 10.1080/21645515.2019.1565269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
28 Lees C, Godin J, McElhaney JE, McNeil SA, Loeb M, Hatchette TF, LeBlanc J, Bowie W, Boivin G, McGeer A, Poirier A, Powis J, Semret M, Webster D, Andrew MK. Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults. J Infect Dis 2020;222:428-37. [PMID: 32147711 DOI: 10.1093/infdis/jiaa092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
29 Meng Z, Zhang J, Shi J, Zhao W, Huang X, Cheng L, Yang X. Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness. Hum Vaccin Immunother 2020;16:2680-9. [PMID: 32347787 DOI: 10.1080/21645515.2020.1747375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Pawelec G, McElhaney J. Recent advances in influenza vaccines. F1000Res 2020;9:F1000 Faculty Rev-305. [PMID: 32399192 DOI: 10.12688/f1000research.22611.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Domaszewska K, Boraczyński M, Tang YY, Gronek J, Wochna K, Boraczyński T, Wieliński D, Gronek P. Protective Effects of Exercise Become Especially Important for the Aging Immune System in The Covid-19 Era. Aging Dis 2022;13:129-43. [PMID: 35111366 DOI: 10.14336/AD.2021.1219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fulop T, Larbi A, Pawelec G, Khalil A, Cohen AA, Hirokawa K, Witkowski JM, Franceschi C. Immunology of Aging: the Birth of Inflammaging. Clin Rev Allergy Immunol 2021. [PMID: 34536213 DOI: 10.1007/s12016-021-08899-6] [Reference Citation Analysis]
33 Wu X, Yang H, He S, Xia T, Chen D, Zhou Y, Liu J, Liu M, Sun Z. Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies. Front Immunol 2022;13:872542. [PMID: 35592323 DOI: 10.3389/fimmu.2022.872542] [Reference Citation Analysis]
34 Andrew MK, McNeil SA. Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective. Vaccine 2021;39 Suppl 1:A36-41. [PMID: 32958335 DOI: 10.1016/j.vaccine.2020.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Veronese N, Demurtas J, Smith L, Michel JP, Barbagallo M, Bolzetta F, Noale M, Maggi S. Influenza vaccination reduces dementia risk: A systematic review and meta-analysis. Ageing Res Rev 2022;73:101534. [PMID: 34861456 DOI: 10.1016/j.arr.2021.101534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
36 Coll PP, Costello VW, Kuchel GA, Bartley J, McElhaney JE. The Prevention of Infections in Older Adults: Vaccination. J Am Geriatr Soc 2020;68:207-14. [PMID: 31613000 DOI: 10.1111/jgs.16205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]